Extending the Scope of PARP Inhibitors in Ovarian Cancer

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(19)30019-1
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Elsevier BV